j*****2
发帖数: 306 | 1 anyone said said about AEN's 4/14 prestention?? | s**********9
发帖数: 846 | 2 Look pretty good. it might run to 2.5 soon. | y*****l
发帖数: 5997 | 3 Adeona Pharmaceuticals receives grant from NMSS for multiple sclerosis trial
2 hours 23 minutes ago - DTM via Comtex
DatamonitorAdeona Pharmaceuticals, Inc., a pharmaceutical company, has
announced that the ongoing clinical trial of its Trimesta, an oral estriol,
drug candidate received an additional $409,426 in grant funding from the
National Multiple Sclerosis Society, or NMSS.
The clinical trial is led by, Rhonda Voskuhl, M.D., Director, University of
California Los Angeles (UCLA) Multiple Sclerosis Program, UCLA Department of
Neurology. Adeona also announced that the clinical trial evaluating the
reduction in the rate of relapses in female multiple sclerosis (MS) patients
is 85% enrolled.
The 150-patient, randomized, double-blind, placebo-controlled clinical trial
of Trimesta is currently underway at 15 centers in the US. Investigators
are administering either Trimesta or matching placebo along with glatimer
acetate (Copaxone), an FDA-approved therapy for MS, to women between the
ages of 18-50 who have been recently diagnosed with relapsing-remitting MS.
With 127 out of 150 patients enrolled in the clinical trial by March 1, 2011
, the Company anticipates full enrollment by the second half of 2011.
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is
expressly prohibited without prior written consent. Datamonitor shall not be
liable for errors or delays in the content, or for any actions taken in
reliance thereon |
|
